Filed: 11/14/2023ACC: 0000950123-23-010374
📋 What this filing means
INTERNATIONAL BIOTECHNOLOGY TRUST PLC filed this quarterly 13F‑HR report disclosing 65 equity positions with a total reported market value of $296.85M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
65
Positions
$296.85M
Total AUM (reported)
11.95M
Total Shares
Allocation by class
COM$255.24M86.0%
CL A$10.38M3.5%
SHS$8.33M2.8%
SPONSORED ADR$5.43M1.8%
COM NEW$4.75M1.6%
SPONSORED ADS$4.52M1.5%
NAMEN AKT$2.86M1.0%
Portfolio Concentration
Top 3$59.51M20.0%
4–10$82.32M27.7%
11–25$91.82M30.9%
Rest$63.19M21.3%
Top 3 weight
20.0%
Top 10 weight
47.8%
Voting Authority Distribution
Total shares with voting rights: 11.95M
Sole
Full voting authority
11.95M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole65
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings65
Rows:
AMGEN INC COM
SOLEShares79.25K
TypeSH
Market value$21.30M
7.17%
Sole
79.25K
Shared
0.00
None
0.00
INCYTE CORP INC COM
SOLEShares358.45K
TypeSH
Market value$20.70M
6.97%
Sole
358.45K
Shared
0.00
None
0.00
GILEAD SCIENCES INC COMMO
SOLEShares233.58K
TypeSH
Market value$17.51M
5.90%
Sole
233.58K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES
SOLEShares317.86K
TypeSH
Market value$16.55M
5.57%
Sole
317.86K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL I
SOLEShares153.66K
TypeSH
Market value$13.60M
4.58%
Sole
153.66K
Shared
0.00
None
0.00
SUPERNUS PHARMACEUTICALS
SOLEShares426.50K
TypeSH
Market value$11.75M
3.96%
Sole
426.50K
Shared
0.00
None
0.00
VERA THERAPEUTICS
SOLEShares758.36K
TypeSH
Market value$10.38M
3.50%
Sole
758.36K
Shared
0.00
None
0.00
BIOGEN INC COMMON STOCK
SOLEShares40.20K
TypeSH
Market value$10.33M
3.48%
Sole
40.20K
Shared
0.00
None
0.00
Harmony Biosciences Holdi
SOLEShares314.50K
TypeSH
Market value$10.31M
3.47%
Sole
314.50K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC C
SOLEShares216K
TypeSH
Market value$9.40M
3.17%
Sole
216K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL
SOLEShares250.05K
TypeSH
Market value$8.91M
3.00%
Sole
250.05K
Shared
0.00
None
0.00
UNIQURE N.V. COM EUR0.05
SOLEShares1.24M
TypeSH
Market value$8.33M
2.81%
Sole
1.24M
Shared
0.00
None
0.00
AURINIA PHARMACEUTICALS I
SOLEShares1.04M
TypeSH
Market value$8.07M
2.72%
Sole
1.04M
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares33.96K
TypeSH
Market value$7.66M
2.58%
Sole
33.96K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS IN
SOLEShares21K
TypeSH
Market value$7.30M
2.46%
Sole
21K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares8.85K
TypeSH
Market value$7.28M
2.45%
Sole
8.85K
Shared
0.00
None
0.00
ILLUMINA INC COM
SOLEShares50.50K
TypeSH
Market value$6.93M
2.34%
Sole
50.50K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS I
SOLEShares36.80K
TypeSH
Market value$6.52M
2.20%
Sole
36.80K
Shared
0.00
None
0.00
AMYLYX PHARMS.
SOLEShares295K
TypeSH
Market value$5.40M
1.82%
Sole
295K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC COM
SOLEShares46.09K
TypeSH
Market value$5.34M
1.80%
Sole
46.09K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC C
SOLEShares30.50K
TypeSH
Market value$5.16M
1.74%
Sole
30.50K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares58.30K
TypeSH
Market value$4.07M
1.37%
Sole
58.30K
Shared
0.00
None
0.00
ERASCA INC COM
SOLEShares1.93M
TypeSH
Market value$3.79M
1.28%
Sole
1.93M
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS IN
SOLEShares179.70K
TypeSH
Market value$3.74M
1.26%
Sole
179.70K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares288.73K
TypeSH
Market value$3.31M
1.11%
Sole
288.73K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMGEN INC COMSOLE | COM | 79.25K | SH | $21.30M 7.17% | 79.25K | 0.00 | 0.00 |
INCYTE CORP INC COMSOLE | COM | 358.45K | SH | $20.70M 6.97% | 358.45K | 0.00 | 0.00 |
GILEAD SCIENCES INC COMMOSOLE | COM | 233.58K | SH | $17.51M 5.90% | 233.58K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIESSOLE | COM | 317.86K | SH | $16.55M 5.57% | 317.86K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL ISOLE | COM | 153.66K | SH | $13.60M 4.58% | 153.66K | 0.00 | 0.00 |
SUPERNUS PHARMACEUTICALSSOLE | COM | 426.50K | SH | $11.75M 3.96% | 426.50K | 0.00 | 0.00 |
VERA THERAPEUTICSSOLE | CL A | 758.36K | SH | $10.38M 3.50% | 758.36K | 0.00 | 0.00 |
BIOGEN INC COMMON STOCKSOLE | COM | 40.20K | SH | $10.33M 3.48% | 40.20K | 0.00 | 0.00 |
Harmony Biosciences HoldiSOLE | COM | 314.50K | SH | $10.31M 3.47% | 314.50K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INC CSOLE | COM | 216K | SH | $9.40M 3.17% | 216K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICALSOLE | COM | 250.05K | SH | $8.91M 3.00% | 250.05K | 0.00 | 0.00 |
UNIQURE N.V. COM EUR0.05SOLE | SHS | 1.24M | SH | $8.33M 2.81% | 1.24M | 0.00 | 0.00 |
AURINIA PHARMACEUTICALS ISOLE | COM | 1.04M | SH | $8.07M 2.72% | 1.04M | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 33.96K | SH | $7.66M 2.58% | 33.96K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INSOLE | COM | 21K | SH | $7.30M 2.46% | 21K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 8.85K | SH | $7.28M 2.45% | 8.85K | 0.00 | 0.00 |
ILLUMINA INC COMSOLE | COM | 50.50K | SH | $6.93M 2.34% | 50.50K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS ISOLE | COM | 36.80K | SH | $6.52M 2.20% | 36.80K | 0.00 | 0.00 |
AMYLYX PHARMS.SOLE | COM | 295K | SH | $5.40M 1.82% | 295K | 0.00 | 0.00 |
KRYSTAL BIOTECH INC COMSOLE | COM | 46.09K | SH | $5.34M 1.80% | 46.09K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INC CSOLE | COM | 30.50K | SH | $5.16M 1.74% | 30.50K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 58.30K | SH | $4.07M 1.37% | 58.30K | 0.00 | 0.00 |
ERASCA INC COMSOLE | COM | 1.93M | SH | $3.79M 1.28% | 1.93M | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INSOLE | COM | 179.70K | SH | $3.74M 1.26% | 179.70K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 288.73K | SH | $3.31M 1.11% | 288.73K | 0.00 | 0.00 |
Page 1 of 3